Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 108Carcinoma, Renal Cell 36Melanoma 13Kidney Neoplasms 13Neoplasm Metastasis 11Urinary Bladder Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 9Brain Neoplasms 9Sarcoma 8Lung Neoplasms 8Prostate Cancer Metastatic 6Neoplasms 5Carcinoma, Transitional Cell 5Adenocarcinoma 5Prostate Adenocarcinoma 4Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Clear-cell metastatic renal cell carcinoma 3Thyroid Neoplasms 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Osteosarcoma 2Oligometastatic Prostate Cancer 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphatic Metastasis 2Local Recurrence of Malignant Tumor of Prostate 2Colorectal Neoplasms 2Colonic Neoplasms 2

Interventions

Radiosurgery 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intraprostatic Prostate Cancer × Radiosurgery × Genitourinary × Clear all
NCT07142967 2025-08-27

Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)

NYU Langone Health

Phase NA Recruiting
28 enrolled
Genitourinary

Intraprostatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡